Ciebiera, Michał http://orcid.org/0000-0001-5780-5983
Ali, Mohamed
Prince, Lillian
Zgliczyński, Stanisław
Jakiel, Grzegorz
Al-Hendy, Ayman
Funding for this research was provided by:
National Institutes of Health (R01 HD094378-04, R01 ES 028615-02, R01 HD100367-01, U54 MD007602, R01 HD094380-02)
Article History
Received: 1 June 2020
Accepted: 19 October 2020
First Online: 27 October 2020
Compliance with Ethical Standards
:
: Ayman Al-Hendy is a consultant for Abbvie, Allergan, Bayer, Myovant Sciences, and Repros. No conflicts were declared for the remaining authors.